Streamlining SARS-CoV-2 confirmatory testing to reduce false positive results
- PMID: 33607351
- PMCID: PMC7877812
- DOI: 10.1016/j.jcv.2021.104762
Streamlining SARS-CoV-2 confirmatory testing to reduce false positive results
Abstract
Background: Confirmatory testing of SARS-CoV-2 results is essential to reduce false positives, but comes at a cost of significant extra workload for laboratories and increased turnaround time. A balance must be sought. We analysed our confirmatory testing pathway to produce a more refined approach in preparation for rising case numbers.
Methods: Over a 10-week low prevalence period we performed confirmatory testing on all newly positive results. Turnaround time was measured and results were analysed to identify a threshold that could be applied as a cut-off for future confirmatory testing and reduce overall workload for the laboratory.
Results: Between 22/06/20 and 31/08/20 confirmatory testing was performed on 108 newly positive samples, identifying 32 false positive results (30 %). Turnaround time doubled, increasing by an extra 17 h. There was a highly statistically significant difference between initial Relative Light Unit (RLU) of results that confirmed compared to those that did not, 1176 vs 721 (P < 0.00001). RLU = 1000 was identified as a suitable threshold for confirmatory testing in our laboratory: with RLU ≥ 1000, 55/56 (98 %) confirmed as positive, whereas with RLU < 1000 only 12/38 (32 %) confirmed.
Conclusions: False positive SARS-CoV-2 tests can be identified by confirmatory testing, yet this may significantly delay results. Establishing a threshold for confirmatory testing streamlines this process to focus only on samples where it is most required. We advise all laboratories to follow a similar process to identify thresholds that trigger confirmatory testing for their own assays, increasing accuracy while maintaining efficiency for when case numbers are high.
Keywords: COVID-19; Confirmatory testing; False positive; Laboratory diagnosis; SARS-CoV-2.
Copyright © 2021 Elsevier B.V. All rights reserved.
Conflict of interest statement
The authors have nothing to declare.
Figures


Similar articles
-
The Hologic Aptima SARS-CoV-2 assay enables high ratio pooling saving reagents and improving turnaround time.J Clin Lab Anal. 2021 Sep;35(9):e23888. doi: 10.1002/jcla.23888. Epub 2021 Jul 2. J Clin Lab Anal. 2021. PMID: 34213803 Free PMC article.
-
Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting.Clin Microbiol Infect. 2021 Mar;27(3):469.e9-469.e15. doi: 10.1016/j.cmi.2020.10.003. Epub 2020 Oct 14. Clin Microbiol Infect. 2021. PMID: 33068757 Free PMC article.
-
SARS-CoV-2 detection by reverse transcriptase polymerase chain reaction testing: Analysis of false positive results and recommendations for quality control measures.Pathol Res Pract. 2021 Sep;225:153579. doi: 10.1016/j.prp.2021.153579. Epub 2021 Aug 4. Pathol Res Pract. 2021. PMID: 34385110 Free PMC article.
-
In vitro diagnostics of coronavirus disease 2019: Technologies and application.J Microbiol Immunol Infect. 2021 Apr;54(2):164-174. doi: 10.1016/j.jmii.2020.05.016. Epub 2020 Jun 5. J Microbiol Immunol Infect. 2021. PMID: 32513617 Free PMC article. Review.
-
Potential false-positive reasons for SARS-CoV-2 antibody testing and its solution.J Med Virol. 2021 Jul;93(7):4242-4246. doi: 10.1002/jmv.26937. Epub 2021 Mar 25. J Med Virol. 2021. PMID: 33710634 Free PMC article. Review.
Cited by
-
Anorexia nervosa and COVID-19 infection: Clinical case report.Clin Case Rep. 2022 Sep 2;10(9):e6216. doi: 10.1002/ccr3.6216. eCollection 2022 Sep. Clin Case Rep. 2022. PMID: 36093463 Free PMC article.
-
Exploring beyond the limit: How comparative stochastic performance affects retesting outcomes in six commercial SARS CoV-2 nucleic acid amplification tests.J Clin Virol Plus. 2022 Aug;2(3):100079. doi: 10.1016/j.jcvp.2022.100079. Epub 2022 Apr 30. J Clin Virol Plus. 2022. PMID: 35528049 Free PMC article.
-
Using Real-Time PCR Fluorescence Reaction Values to Improve SARS-CoV-2 Virus Detection and Benefit Clinical Decision-Making.Life (Basel). 2023 Mar 2;13(3):683. doi: 10.3390/life13030683. Life (Basel). 2023. PMID: 36983837 Free PMC article.
-
Comparison of the performance of two real-time fluorescent quantitative PCR kits for the detection of SARS-CoV-2 nucleic acid: a study based on large real clinical samples.Virol J. 2022 Nov 18;19(1):191. doi: 10.1186/s12985-022-01922-y. Virol J. 2022. PMID: 36401275 Free PMC article.
References
-
- GOV.UK, Public Health England, Coronavirus (COVID-19) in the UK [Internet]. Updated 14/12/2020 [cited 15/12/2020]. Available from: https://coronavirus.data.gov.uk/testing.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous